The revolution of immuno-oncology therapy: review of immune checkpoint inhibitors efficacy & specificities for the physicians

At the request of the CEO of Inserm, the laboratory will be closed for an indefinite period.

Prize awarded at the 19th Annual Congress of the European Society for Photodynamic Therapy, 28-29 February, Seville, Spain

OncoThAI will be present in Seville at the next congress organized by the European Society of Photodynamic Therapy.

OncoThAI's  research work is named in the "Health Trophies" category with the FLUXMEDICARE device manufactured and marketed by the company TEXINOV

Pr. Serge Mordon was invited to join the Board of Pharmaceuticals.